New Breathe is an online technology service for clinical trial scenarios. Based on the information on the page, its core positioning is to use online mechanisms to streamline the recruitment process for clinical trial participants, with follow-up handled by professional medical staff. It appears to be a vertical solution focused on clinical research operations rather than a general-purpose enterprise SaaS product.
The currently confirmed capabilities are mainly twofold: first, it supports moving clinical trial recruitment workflows online and improving efficiency; second, it provides follow-up services involving professional healthcare personnel. The website does not disclose specific modules such as participant screening, appointment scheduling, electronic informed consent, CRM, message outreach, data dashboards, permission management, or similar features, so it is not possible to determine whether it offers the capabilities of a full clinical trial management platform.
The crawled content does not include plans, pricing models, free trial details, or demo request information. It also does not state whether billing is project-based, site-based, patient-volume-based, or subscription-based. The deployment model is likewise unknown, so it cannot be confirmed whether it is a pure cloud SaaS, self-hosted solution, or custom service delivery.
The page does not mention third-party integrations with EDC, CTMS, ePRO, electronic medical records, email/SMS platforms, payment systems, or similar tools. It also provides no API, developer documentation, or Webhook information. Given that it involves clinical trials and medical follow-up, data privacy, healthcare compliance, access control, and audit capabilities are highly important, but the available text does not disclose HIPAA, GDPR, or other compliance measures.
Its strengths are its clear positioning, focus on the high-friction processes of clinical trial recruitment and follow-up, and emphasis on participation by professional medical staff. It may be suitable for clinical research organizations, trial sponsors, CROs, or healthcare institutions to evaluate. The main drawback is the limited public information available, making it difficult to assess product maturity, implementation complexity, service coverage regions, and support quality.
Access from mainland China is unknown, and payment methods are not disclosed. If conducting clinical research in China, it is important to verify network availability, cross-border data transfer requirements, privacy compliance, local medical resources, and Chinese-language support. Possible alternatives to compare include local CRO recruitment services, clinical trial management systems, or patient recruitment platforms.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on newbreathe.org official site.
newbreathe.org is an Unknown SaaS Tools provider. TG4G tracks its product information, an overall rating of 5.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach newbreathe.org directly.